Skip to main content
Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery 2/2022

28.09.2020 | COVID-19 | Original Article Zur Zeit gratis

Emergence and Evolution of Olfactory and Gustatory Symptoms in Patients with COVID-19 in the Outpatient Setting

verfasst von: Mahboobeh Karimi-Galougahi, Ali Safavi Naini, Jahangir Ghorbani, Nasim Raad, Negar Raygani

Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery | Sonderheft 2/2022

Einloggen, um Zugang zu erhalten

Abstract

The present study aimed at evaluating the prevalence of general and sinonasal symptoms in patients with olfactory symptoms and mild coronavirus disease-2019 (COVID-19) and determining the patterns in emergence and resolution of olfactory/gustatory symptoms relative to general and sinonassal symptoms. This was a prospective cross-sectional study conducted at the outpatient otorhinolaryngology clinic at a COVID-19-designated referral Hospital. We included consecutive patients with new-onset olfactory dysfunction and positive polymerase chain reaction (PCR) assay of COVID-19. We asked the patients to fill in a questionnaire about general and sinonasal symptoms in association with anosmia, hyposmia or hypogeusia, and recorded the time course of the olfactory/gustatory symptoms during 2-weeks of follow-up. 76 patients with average age of 38.5 ± 10.6 years were included. Majority of participants (94.7%) had general or sinonasal symptom. There was anosmia in 60.5% and hyposmia in 39.5%, with sudden onset of olfactory symptoms reported in 63.2% of patients. During the follow-up, 30.3% of patients completely and 44.7% partially recovered from anosmia/hyposmia. Regardless of whether the general or olfactory symptoms appeared initially, the general symptoms resolved first while a degree of olfactory dysfunction persisted during the follow-up. Our study showed that hyposmia and anosmia in mild COVID-19 are frequently associated with general and sinonasal symptoms and tend to persist longer than the general and sinonasal symptoms during the course of the disease.
Literatur
1.
Zurück zum Zitat Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W et al (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579:270–273CrossRefPubMedCentralPubMed Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W et al (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579:270–273CrossRefPubMedCentralPubMed
2.
Zurück zum Zitat Li Y, Bai WZ, Hashikawa T (2020) Response to commentary on: “The neuroinvasive potential of SARS-CoV-2 may play a role in the respiratory failure of COVID-19 patients”. J Med Virol 92:707–709CrossRefPubMedCentralPubMed Li Y, Bai WZ, Hashikawa T (2020) Response to commentary on: “The neuroinvasive potential of SARS-CoV-2 may play a role in the respiratory failure of COVID-19 patients”. J Med Virol 92:707–709CrossRefPubMedCentralPubMed
3.
Zurück zum Zitat Fang Y, Zhang H, Xie J, Lin M, Ying L, Pang P et al (2020) Sensitivity of chest CT for COVID-19: comparison to RT-PCR. Radiology 296:E115–E117CrossRefPubMed Fang Y, Zhang H, Xie J, Lin M, Ying L, Pang P et al (2020) Sensitivity of chest CT for COVID-19: comparison to RT-PCR. Radiology 296:E115–E117CrossRefPubMed
4.
Zurück zum Zitat Xu X, Yu C, Qu J, Zhang L, Jiang S, Huang D et al (2020) Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2. Eur J Nucl Med Mol I 47:1275–1280CrossRef Xu X, Yu C, Qu J, Zhang L, Jiang S, Huang D et al (2020) Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2. Eur J Nucl Med Mol I 47:1275–1280CrossRef
5.
Zurück zum Zitat Ruan Q, Yang K, Wang W, Jiang L, Song J (2020) Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan. China Intensive Care Med 46:846–848CrossRefPubMed Ruan Q, Yang K, Wang W, Jiang L, Song J (2020) Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan. China Intensive Care Med 46:846–848CrossRefPubMed
6.
7.
Zurück zum Zitat Sungnak W, Huang N, Bécavin C, Berg M, Queen R, Litvinukova M et al (2020) SARS-CoV-2 Entry genes are most highly expressed in nasal goblet and ciliated cells within human airways. Nat Med 26:681–687CrossRefPubMedCentralPubMed Sungnak W, Huang N, Bécavin C, Berg M, Queen R, Litvinukova M et al (2020) SARS-CoV-2 Entry genes are most highly expressed in nasal goblet and ciliated cells within human airways. Nat Med 26:681–687CrossRefPubMedCentralPubMed
9.
Zurück zum Zitat Mao L, Jin H, Wang M, Hu Y, Chen S, He Q et al (2020) Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 10(77):1–9 Mao L, Jin H, Wang M, Hu Y, Chen S, He Q et al (2020) Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 10(77):1–9
11.
Zurück zum Zitat Karimi-Galougahi M, Raad N, Mikaniki N (2020) Anosmia and the need for COVID-19 screening during the pandemic. Otolaryngol Head Neck Surg 163:96–97CrossRefPubMed Karimi-Galougahi M, Raad N, Mikaniki N (2020) Anosmia and the need for COVID-19 screening during the pandemic. Otolaryngol Head Neck Surg 163:96–97CrossRefPubMed
12.
Zurück zum Zitat Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A et al (2020) Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol 277:2251–2261CrossRefPubMedCentralPubMed Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A et al (2020) Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol 277:2251–2261CrossRefPubMedCentralPubMed
13.
Zurück zum Zitat Kaye R, Chang D, Kazahaya K, Brereton J, Denneny JC (2020) COVID-19 anosmia reporting tool: initial findings. Otolaryngol Head Neck Surg 163:132–134CrossRefPubMed Kaye R, Chang D, Kazahaya K, Brereton J, Denneny JC (2020) COVID-19 anosmia reporting tool: initial findings. Otolaryngol Head Neck Surg 163:132–134CrossRefPubMed
15.
Zurück zum Zitat Giacomelli A, Pezzati L, Conti F, Bernacchia D, Siano M, Oreni L et al (2020) Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study. Clin Infect Dis 71:889–890CrossRefPubMed Giacomelli A, Pezzati L, Conti F, Bernacchia D, Siano M, Oreni L et al (2020) Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study. Clin Infect Dis 71:889–890CrossRefPubMed
16.
Zurück zum Zitat Cavazzana A, Larsson M, Münch M, Hähner A, Hummel T (2018) Postinfectious olfactory loss: a retrospective study on 791 patients. Laryngoscope 128:10–15CrossRefPubMed Cavazzana A, Larsson M, Münch M, Hähner A, Hummel T (2018) Postinfectious olfactory loss: a retrospective study on 791 patients. Laryngoscope 128:10–15CrossRefPubMed
17.
Zurück zum Zitat London B, Nabet B, Fisher AR, White B, Sammel MD, Doty RL (2008) Predictors of prognosis in patients with olfactory disturbance. Ann Neurol 63:159–166CrossRefPubMed London B, Nabet B, Fisher AR, White B, Sammel MD, Doty RL (2008) Predictors of prognosis in patients with olfactory disturbance. Ann Neurol 63:159–166CrossRefPubMed
18.
19.
Zurück zum Zitat Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S et al (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181:271–280.e8CrossRefPubMedCentralPubMed Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S et al (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181:271–280.e8CrossRefPubMedCentralPubMed
20.
Zurück zum Zitat Butowt R, Bilinska K (2020) SARS-CoV-2: olfaction, brain infection, and the urgent need for clinical samples allowing earlier virus detection. ACS Chem Neurosci 11:1200–1203CrossRefPubMed Butowt R, Bilinska K (2020) SARS-CoV-2: olfaction, brain infection, and the urgent need for clinical samples allowing earlier virus detection. ACS Chem Neurosci 11:1200–1203CrossRefPubMed
21.
Zurück zum Zitat Karimi-Galougahi M, Ghorbani J, Bakhshayeshkaram M, SafaviNaeini A, Haseli S (2020) Olfactory bulb magnetic resonance imaging in SARS-CoV-2-induced anosmia: the first report. Acad Radiol 27:892–893CrossRef Karimi-Galougahi M, Ghorbani J, Bakhshayeshkaram M, SafaviNaeini A, Haseli S (2020) Olfactory bulb magnetic resonance imaging in SARS-CoV-2-induced anosmia: the first report. Acad Radiol 27:892–893CrossRef
Metadaten
Titel
Emergence and Evolution of Olfactory and Gustatory Symptoms in Patients with COVID-19 in the Outpatient Setting
verfasst von
Mahboobeh Karimi-Galougahi
Ali Safavi Naini
Jahangir Ghorbani
Nasim Raad
Negar Raygani
Publikationsdatum
28.09.2020
Verlag
Springer India
Schlagwort
COVID-19
Erschienen in
Indian Journal of Otolaryngology and Head & Neck Surgery / Ausgabe Sonderheft 2/2022
Print ISSN: 2231-3796
Elektronische ISSN: 0973-7707
DOI
https://doi.org/10.1007/s12070-020-02166-4

Weitere Artikel der Sonderheft 2/2022

Indian Journal of Otolaryngology and Head & Neck Surgery 2/2022 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.